|
Chiesi will assume ownership of Ekterly, an on-demand pill approved for hereditary angioedema.
|
 |
|
This deal falls under Teva’s wider strategy to prioritise strategic, financially diligent deals around de-risked, differentiated, late-stage assets.
|
|
|
Regeneron’s total revenue increased 19% year-on-year to $3.6bn from $3.02bn.
|
|
|
With publication of the first JCA report imminent, procedural and methodological challenges persist.
|
|
|
The PRIME status for RTx-015 was granted based on preliminary Phase I/II safety and efficacy clinical data.
|
|
